Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Morphological features of platelet-rich plasma on acellular vascular scaffolds.

International journal of surgery (London, England)·2025

Same author

Discovery of naturally inspired antimicrobial peptides using deep learning.

Bioorganic chemistry·2025

Same author

CDK14 regulates the development and repair of lung.

Cell death discovery·2025

Same author

Exploring the Diversity and Specificity of Secondary Biosynthetic Potential in <i>Rhodococcus</i>.

Marine drugs·2024

Same author

The first large scale rDNA amplicon database of soil microbiomes from Pamir Plateau, China.

Scientific data·2024

Same author

Functional vertical connectivity of microbial communities in the ocean.

Science advances·2024

Search research articles

Related Experiment Video

Updated: Jun 10, 2025

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

ATN-161 alleviates caerulein-induced pancreatitis.

Rong-Rong Gao¹, Lan-Yue Ma², Jian-Wei Chen³

¹Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, Shandong 250117, China.

Journal of Genetics and Genomics = Yi Chuan Xue Bao

|October 13, 2024

Summary

The study shows that blocking Integrin-α5 signaling with ATN-161 effectively treats acute pancreatitis. This approach reduces pathological changes and offers a new therapeutic strategy for gastrointestinal disorders.

Keywords:

ATN-161 Acinar-to-ductal metaplasia Angiogenesis Ductal-endothelial crosstalk Pancreatitis

More Related Videos

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

Published on: February 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Related Experiment Videos

Last Updated: Jun 10, 2025

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion

Published on: February 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Area of Science:

Gastroenterology
Cell Biology
Pharmacology

Background:

Pancreatitis is a prevalent gastrointestinal disorder with high morbidity and mortality.
Complex pathophysiology hinders effective pharmacological interventions for pancreatitis.
The role of ductal-endothelial interactions in pancreatitis remains unclear.

Purpose of the Study:

To investigate the therapeutic potential of ATN-161, an Integrin-α5 antagonist, in acute pancreatitis.
To elucidate the role of the ductal-endothelial interface in pancreatitis pathogenesis.
To explore the Spp-1/Integrin-α5 signaling pathway in pancreatitis.

Main Methods:

Utilized a caerulein-induced acute pancreatitis mouse model.
Employed single-cell RNA sequencing to analyze ductal and endothelial cell interactions.
Administered ATN-161 to assess its therapeutic effects on pancreatitis pathology.

Main Results:

ATN-161 administration significantly mitigated acute pancreatitis induced by caerulein.
Pancreatitis disrupted ductal-endothelial crosstalk but promoted Spp-1/Integrin-α5 signaling.
ATN-161 treatment reduced acinar-to-ductal metaplasia and pathological angiogenesis.

Conclusions:

The study identifies a novel therapeutic strategy targeting Spp-1/Integrin-α5 signaling for pancreatitis.
ATN-161 demonstrates significant potential in alleviating pancreatitis symptoms and pathological defects.
Understanding the ductal-endothelial interface offers new insights into pancreatitis mechanisms.